- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05744388
Modification of the Stylet Shape of the Glidescope for Facilitating Difficult Intubation
Efficacy of Lubricating the Under Surface of Glidescope Blade Stylet Shape Modification to Facilitate Endotracheal Intubation for Suspected Difficult Intubation; A Prospective Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Endotracheal tube diameter size 7.5 mm and disposable rigid blade size 3 for the female patients and ETT diameter size 8.00 mm and disposable rigid blade size 4 for the male patients will be prepared. The under surface of the blade will be lubricated by soluble jelly, taking care not to touch the camera source of light.
The stylet will be more obtuse angle than the standard shape. The stylet will be lubricated also before being fitted inside the endotracheal tube. The blade will be introduced inside the mouth midline, the tube will be held from the upper third and introduced in the midline also sliding over the blade and introduced inside the glottis. Once the tip of the tube introduced inside the glottis, the stylet will be removed and the tube will be advanced more inside the trachea. The equality of air entry will be assessed by the stethoscope and the tube will by fixed by adhesive tape after inflating the cuff.
If during intubation the used technique failed to introduce the tube, we will do ETT rotation inside the mouth or upward stylet angulation outside the mouth then will be reintroduced again. If Glidescope failed to intubate, we will use intubating LMA to intubate the patients. If all trials failed to intubate the patients. Sugamadex 16 mg/Kg will be injected to awaken the patients. After intubation the large gastric tube will be introduced in the esophagus under vision by the Glidescope help also.
Group 2:
The second group will be a control group, they will be handled by the standard shape of the stylet and the blade without lubrication.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sabah Ayoub, MD
- Phone Number: 563887242 966563887242
- Email: sabah_nageeb@med.asu.edu.eg
Study Contact Backup
- Name: Rabah Alharbi, Saudi board
- Phone Number: 0555595373 9660555595373
- Email: rabahsa@moh.gov.sa
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA physical status II or III
- BMI more than 35
- Patients presenting with at least one predictor for a difficult airway.
- The airway difficulty is at least score 3 as an indicator of difficulty.
Exclusion Criteria:
- Patients who may need rapid sequence induction
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Stylet shape modification group
Endotracheal tube diameter size 7.5 mm and disposable rigid blade size 3 for the female patients and ETT diameter size 8.00 mm and disposable rigid blade size 4 for the male patients will be prepared. The under surface of the blade will be lubricated by soluble jelly, taking care not to touch the camera source of light. The stylet will be more obtuse angle than the standard shape. The stylet will be lubricated also before being fitted inside the endotracheal tube. The blade will be introduced inside the mouth midline, the tube will be held from the upper third and introduced in the midline also sliding over the blade and introduced inside the glottis. Once the tip of the tube introduced inside the glottis, the stylet will be removed and the tube will be advanced more inside the trachea. The equality of air entry will be assessed by the stethoscope and the tube will by fixed by adhesive tape after inflating the cuff. |
The stylet will be more obtuse angle than the standard shape.
The stylet will be lubricated also before being fitted inside the endotracheal tube.
The blade will be introduced inside the mouth midline, the tube will be held from the upper third and introduced in the midline also sliding over the blade and introduced inside the glottis.
Other Names:
|
No Intervention: Standard shape of the stylet group
The second group will be a control group, they will be handled by the standard shape of the stylet and the blade without lubrication.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intubation time in seconds
Time Frame: intraoperative time
|
the intubation time will be calculated in seconds from the video screen of the Glidescope watch
|
intraoperative time
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of trials of endotracheal intubation
Time Frame: intraoperative time
|
the intubation time will be recorded
|
intraoperative time
|
mucosal damage during the intubation
Time Frame: intraoperative time
|
The blade under surface will be observed for blood spots.
And the oral cavity will be viewed for mucosal damage or obscured view.
|
intraoperative time
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sabah Ayoub, MD, ain shams University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Glidescope
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Difficult Intubation
-
Lazarski UniversityCompletedIntubation; Difficult or Failed | Difficult Airway | Intubation;DifficultPoland
-
Catharina Ziekenhuis EindhovenCompletedAnesthesia Intubation Complication | Intubation; Difficult | Failed or Difficult Intubation | Failed or Difficult Intubation, Initial EncounterNetherlands
-
Michael MaRecruitingDifficult Intubation | Difficult Airway IntubationIreland
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntubation Complication | Intubation;Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Singapore
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)RecruitingIntubation Complication | Intubation; Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Japan, Italy, New Zealand, Singapore, Australia, Austria, Germany, India, United Kingdom
-
J. Matthias WalzTerminatedSurgery | Difficult Intubation | Anesthesia | Difficult Airway Intubation | Speech DysfunctionUnited States
-
Derince Training and Research HospitalCompletedDifficult Intubation | Difficult AirwayTurkey
-
University at BuffaloTerminatedIntubation Complication | Intubation;DifficultUnited States
-
University Hospitals Coventry and Warwickshire...Oxford University Hospitals NHS TrustCompletedIntubation;Difficult | Tracheal IntubationUnited Kingdom
-
Heinrich-Heine University, DuesseldorfCompleted
Clinical Trials on Gliderite® shape modification
-
Tianjin Medical University General HospitalNot yet recruiting
-
Xiamen Amoytop Biotech Co., Ltd.Tongji HospitalCompletedGrowth Hormone DeficiencyChina
-
Apollo Endosurgery, Inc.Completed
-
Puerta de Hierro University HospitalHospital Universitario Ramon y Cajal; Hospitales Universitarios Virgen del... and other collaboratorsUnknownObesity | Non-Alcoholic Fatty Liver DiseaseSpain
-
Royal Free Hampstead NHS TrustRoche Pharma AGCompleted
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCCompletedOpioid Use DisorderUnited States
-
Brigham and Women's HospitalBeth Israel Deaconess Medical CenterCompletedObstructive Sleep ApneaUnited States
-
Alkermes, Inc.Completed
-
Boehringer IngelheimCompleted
-
Astellas Pharma Global Development, Inc.National Institute on Drug Abuse (NIDA)Completed